Artwork

Ran Chen에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Ran Chen 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
Player FM -팟 캐스트 앱
Player FM 앱으로 오프라인으로 전환하세요!

Unlocking MENA's Billion-Dollar Dialysis Market: A Pure Global Guide for Hemodialysis and Peritoneal Dialysis Equipment in Saudi Arabia & the UAE

2:57
 
공유
 

Manage episode 510947057 series 3684624
Ran Chen에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Ran Chen 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
In this episode of MENA MedTech Insights, we explore the billion-dollar market for hemodialysis and peritoneal dialysis equipment in the Middle East and North Africa. As rates of chronic kidney disease climb, we uncover the immense opportunities for MedTech manufacturers in key markets like Saudi Arabia and the UAE. We break down the complex and fragmented regulatory environment that often creates significant barriers to entry. We discuss why a one-size-fits-all approach to market registration fails and highlight the critical importance of a localized strategy, deep regulatory intelligence, and navigating the unique requirements of bodies like the Saudi Food and Drug Authority (SFDA). **Case in Point:** A leading European MedTech company developed an innovative peritoneal dialysis machine, but their entry into the lucrative Saudi market was stalled for 18 months. They faced repeated rejections from the SFDA due to documentation details that were compliant in Europe but not in Saudi Arabia. This cost them a multi-million dollar government tender and gave competitors a critical head start. **Key Takeaways From This Episode:** * Why is in-center hemodialysis still dominant in the Gulf, and what will it take for home-based peritoneal dialysis to grow? * What are the most common mistakes device makers make when submitting technical files to the Saudi SFDA? * How can you leverage your existing CE Mark or FDA clearance for faster market access in the UAE and Egypt? * What specific impact does Saudi Vision 2030 have on foreign MedTech companies planning to sell dialysis equipment? * How can appointing a distributor as your sole legal representative create significant business risks down the line? * Are there unique post-market surveillance requirements for dialysis machines in the MENA region you need to be aware of? * How can AI-powered tools dramatically reduce the time and cost of regulatory submissions in this region? At Pure Global, we provide MedTech and IVD companies with end-to-end regulatory consulting solutions to streamline global market access. By combining local expertise in over 30 markets with advanced AI tools, we help you navigate complex regulatory landscapes in the MENA region and beyond. To build your market access strategy, contact us at [email protected] or visit https://pureglobal.com/.
  continue reading

60 에피소드

Artwork
icon공유
 
Manage episode 510947057 series 3684624
Ran Chen에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Ran Chen 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
In this episode of MENA MedTech Insights, we explore the billion-dollar market for hemodialysis and peritoneal dialysis equipment in the Middle East and North Africa. As rates of chronic kidney disease climb, we uncover the immense opportunities for MedTech manufacturers in key markets like Saudi Arabia and the UAE. We break down the complex and fragmented regulatory environment that often creates significant barriers to entry. We discuss why a one-size-fits-all approach to market registration fails and highlight the critical importance of a localized strategy, deep regulatory intelligence, and navigating the unique requirements of bodies like the Saudi Food and Drug Authority (SFDA). **Case in Point:** A leading European MedTech company developed an innovative peritoneal dialysis machine, but their entry into the lucrative Saudi market was stalled for 18 months. They faced repeated rejections from the SFDA due to documentation details that were compliant in Europe but not in Saudi Arabia. This cost them a multi-million dollar government tender and gave competitors a critical head start. **Key Takeaways From This Episode:** * Why is in-center hemodialysis still dominant in the Gulf, and what will it take for home-based peritoneal dialysis to grow? * What are the most common mistakes device makers make when submitting technical files to the Saudi SFDA? * How can you leverage your existing CE Mark or FDA clearance for faster market access in the UAE and Egypt? * What specific impact does Saudi Vision 2030 have on foreign MedTech companies planning to sell dialysis equipment? * How can appointing a distributor as your sole legal representative create significant business risks down the line? * Are there unique post-market surveillance requirements for dialysis machines in the MENA region you need to be aware of? * How can AI-powered tools dramatically reduce the time and cost of regulatory submissions in this region? At Pure Global, we provide MedTech and IVD companies with end-to-end regulatory consulting solutions to streamline global market access. By combining local expertise in over 30 markets with advanced AI tools, we help you navigate complex regulatory landscapes in the MENA region and beyond. To build your market access strategy, contact us at [email protected] or visit https://pureglobal.com/.
  continue reading

60 에피소드

모든 에피소드

×
 
Loading …

플레이어 FM에 오신것을 환영합니다!

플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.

 

빠른 참조 가이드

탐색하는 동안 이 프로그램을 들어보세요.
재생